Statistics

Total Visits

Views
Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients67

Select a period of time:

Number of views in the range

Views
Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients31

Views

Views
June 202510
July 202511
August 20250
September 20252
October 20250
November 20258
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil11
Hong Kong10
United States3
Argentina1
Canada1
Ecuador1
Tunisia1
Turkey1
Venezuela1
South Africa1
 

Top cities views

Views
Hong Kong10
Dallas2
Belo Horizonte2
Ashburn1
Aydin1
Esmeraldas1
Goiânia1
Johannesburg1
Manaus1
Marília1